UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046276
Receipt number R000051545
Scientific Title Study for evaluating clinical efficacy of a recreation program to improve cognitive abilities of elderly people in day care center using eye-tracking-based cognitive assessment.
Date of disclosure of the study information 2022/01/01
Last modified on 2021/12/04 00:08:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study for evaluating clinical efficacy of a recreation program to improve cognitive abilities of elderly people in day care center using eye-tracking-based cognitive assessment.

Acronym

Study for evaluating clinical efficacy of a recreation program to improve cognitive abilities of elderly people in day care center using eye-tracking-based cognitive assessment.

Scientific Title

Study for evaluating clinical efficacy of a recreation program to improve cognitive abilities of elderly people in day care center using eye-tracking-based cognitive assessment.

Scientific Title:Acronym

Study for evaluating clinical efficacy of a recreation program to improve cognitive abilities of elderly people in day care center using eye-tracking-based cognitive assessment.

Region

Japan


Condition

Condition

Mild cognitive impairment

Classification by specialty

Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is evaluating clinical efficacy of a recreation program to improve cognitive abilities of elderly people in day care center.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cognitive score measured by eye-tracking-based cognitive assessment after three months intervention

Key secondary outcomes

Barthel Index after three months intervention
Dementia Behavior Disturbance Scale (DBD13) after three months intervention


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Three-month intervention period
Motor-cognitive dual task trainig, 1-2 times per week

Interventions/Control_2

Three-month intervention period
No intervention

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

People with mild coginitve impairment and at a risk of developing cognitive impairment.

Key exclusion criteria

People with severe hearing or visual impairment are excluded from the study.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Shuko
Middle name
Last name Takeda

Organization

Osaka university

Division name

Graduate school of medicine

Zip code

565-0871

Address

2-2 Yamada-oka, Suita

TEL

0662108351

Email

takeda@cgt.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Shuko
Middle name
Last name Takeda

Organization

Osaka university

Division name

Graduate school of medicine

Zip code

565-0871

Address

2-2 Yamada-oka, Suita

TEL

0662108351

Homepage URL


Email

takeda@cgt.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka university

Institute

Department

Personal name



Funding Source

Organization

Solasto Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka university

Address

2-2 Yamada-oka, Suita

Tel

06-6210-8296

Email

handai-nintei@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 11 Month 25 Day

Date of IRB


Anticipated trial start date

2021 Year 12 Month 06 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 12 Month 04 Day

Last modified on

2021 Year 12 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051545